(MedPage Today) -- Treatment of longstanding moderate-to-severe plaque psoriasis with secukinumab was associated with rapid and dramatic improvements, two large phase III clinical trials found. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment